NASDAQ: VRTX · Health Care / Biotechnology: Pharmaceutical Preparations

Vertex Pharmaceuticals Incorporated

How Vertex Pharmaceuticals Incorporated compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$136.9B

Price

$540.00

P/E

31.1

EPS (TTM)

$17.39

1-year return

28.6%

Dividend yield

0.0%

52-week range

$409.47–$557.96

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector
• S&P 500
• NASDAQ-100

For information only, not investment advice. Data may contain errors. Disclaimer · Sources